×
Close
Sign Up
Login
Home
Library S
Library D
Events & Partner
WeMed
MDLA Events Platform
Events
Media Partners
Educational Partner
User Tools
FAQ/USER GUIDE
Language
English
中文/ Chinese
French
Português
Español
Arabic
Russian
Contact Us
×
Close
mdla_1
mdla_2
mdla_3
mdla_4
mdla_5
mdla_6
Categories
Endocrinology, Metabolism & Nutrition
24725
Global Medical University
5209
Allergy
1834
Anatomy & Morphology
1643
Andrology
394
Anesthesia & Intensive Care
1302
Anesthesiology
5640
Audiology & Speech-Language Pathology
361
Behavioral Sciences
100
Biochemical Research Methods
7148
Biochemistry & Molecular Biology
30450
Biodiversity Conservation
332
Biology
8606
Biophysics
8374
Biotechnology & Applied Microbiology
8589
Cardiac & Cardiovascular Systems
31588
Cardiovascular & Respiratory Systems
1423
Cell & Tissue Engineering
711
Cell Biology
11313
Chemistry, Analytical
4328
Chemistry, Applied
11086
Chemistry, Medicinal
8796
Chemistry, Multidisciplinary
18695
Clinical Immunology & Infectious Disease
482
Clinical Medicine
9019
Clinical Neurology
16946
Clinical Psychology & Psychiatry
1327
Critical Care Medicine
3256
Dentistry, Oral Surgery & Medicine
13699
Dermatology
7623
Developmental Biology
7068
Ecology
663
Education, Scientific Disciplines
2075
Emergency Medicine
4192
Engineering, Biomedical
3818
Entomology
457
Environmental Medicine & Public Health
4783
Evolutionary Biology
283
Gastroenterology & Hepatology
12563
General & Internal Medicine
7102
Genetics & Heredity
15281
Geriatrics & Gerontology
5313
Gerontology
372
Health Care Sciences & Services
16396
Health Policy & Services
656
Hematology
5724
Immunology
25098
Infectious Diseases
14221
Integrative & Complementary Medicine
2976
Medical Ethics
1218
Medical Informatics
2304
Medical Laboratory Technology
433
Medicine, General & Internal
45003
Medicine, Legal
541
Medicine, Research & Experimental
18021
Microbiology
23527
Mycology
0
Nanoscience & Nanotechnology
5441
Neuroimaging
1415
Neurology
4633
Neurosciences
40598
Nursing
9920
Nutrition & Dietetics
7991
Obstetrics & Gynecology
8449
Oncology
53062
Ophthalmology
9870
Optics
4320
Orthopedics
11982
Orthopedics, Rehabilitation & Sports Medicine
1832
Otolaryngology
1612
Otorhinolaryngology
5001
Parasitology
1133
Pathology
5230
Pediatrics
21975
Peripheral Vascular Disease
4963
Pharmacology & Pharmacy
35847
Pharmacology/Toxicology
12194
Physiology
9027
Polymer Science
559
Primary Health Care
893
Psychiatry
19429
Psychology
5377
Psychology, Applied
121
Psychology, Biological
374
Psychology, Clinical
805
Psychology, Developmental
248
Psychology, Educational
169
Psychology, Experimental
176
Psychology, Mathematical
0
Psychology, Multidisciplinary
1731
Psychology, Psychoanalysis
41
Psychology, Social
121
Public Health & Health Care Science
2282
Public, Environmental & Occupational Health
27709
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
12710
Radiology, Nuclear Medicine & Medical Imaging
8265
Rehabilitation
3138
Remote Sensing
0
Reproductive Biology
2917
Reproductive Medicine
1208
Research/Laboratory Medicine & Medical Technology
4043
Respiratory System
7648
Rheumatology
6134
Social Sciences, Biomedical
1247
Substance Abuse
2775
Surgery
34555
Toxicology
4503
Transplantation
955
Tropical Medicine
314
Urology & Nephrology
13395
Veterinary Sciences
35
Virology
2515
Zoology
0
Channels
DIABETES OBESITY & METABOLISM
293
NEJM Endocrinology
9
Medrxiv - Endocrinology Medrxiv
467
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
460
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
214
BIOLOGY OF SEX DIFFERENCES
191
BMJ OPEN DIABETES RESEARCH & CARE
395
BONE
0
CALCIFIED TISSUE INTERNATIONAL
356
CARDIOVASCULAR DIABETOLOGY
637
CURRENT DIABETES REPORTS
177
CURRENT OBESITY REPORTS
132
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY
170
CURRENT OPINION IN LIPIDOLOGY
127
CURRENT OSTEOPOROSIS REPORTS
191
DIABETES
134
DIABETES & METABOLISM
203
DIABETES & METABOLISM JOURNAL
40
DIABETES CARE
194
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
968
DIABETES RESEARCH AND CLINICAL PRACTICE
0
DIABETES-METABOLISM RESEARCH AND REVIEWS
105
DIABETIC MEDICINE
215
DIABETOLOGIA
542
ENDOCRINE
686
ENDOCRINE PATHOLOGY
176
ENDOCRINE PRACTICE
656
EUROPEAN THYROID JOURNAL
19
FRONTIERS IN ENDOCRINOLOGY
5721
HORMONES AND BEHAVIOR
328
JOURNAL OF BONE AND MINERAL RESEARCH
173
JOURNAL OF DIABETES
88
JOURNAL OF DIABETES INVESTIGATION
241
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
637
JOURNAL OF HUMAN NUTRITION AND DIETETICS
112
JOURNAL OF NEUROENDOCRINOLOGY
115
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
252
LANCET DIABETES & ENDOCRINOLOGY
16
METABOLISM-CLINICAL AND EXPERIMENTAL
18
MOLECULAR METABOLISM
570
NATURE REVIEWS ENDOCRINOLOGY
435
NEUROENDOCRINOLOGY
149
NUTRITION & DIABETES
114
OBESITY
133
OBESITY REVIEWS
115
PEDIATRIC DIABETES
87
PSYCHONEUROENDOCRINOLOGY
0
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM
34
ARCHIVES OF ENDOCRINOLOGY METABOLISM
0
CLINICAL ENDOCRINOLOGY
179
DIABETES & VASCULAR DISEASE RESEARCH
16
DIABETOLOGY & METABOLIC SYNDROME
507
ENDOCRINOLOGIA DIABETES Y NUTRICION
397
GENERAL AND COMPARATIVE ENDOCRINOLOGY
0
INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM
170
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
139
JOURNAL OF CLINICAL DENSITOMETRY
265
JOURNAL OF DIABETES AND ITS COMPLICATIONS
437
NEUROIMMUNOMODULATION
83
OBESITY FACTS
160
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
391
WORLD REVIEW OF NUTRITION AND DIETETICS
30
HORMONE AND METABOLIC RESEARCH
350
NEUROPEPTIDES
182
THYROID RESEARCH
101
REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL
44
BRITISH JOURNAL OF DIABETES
135
CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES
20
CLINICAL OBESITY
44
CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM
38
DIABETOLOGY INTERNATIONAL
202
JOURNAL OF DIABETES AND METABOLIC DISORDERS
543
JOURNAL OF DIABETOLOGY
126
JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES
201
OBESITY SCIENCE & PRACTICE
87
PITUITARY
282
OSTEOPOROSIS INTERNATIONAL
603
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
272
DIABETES THERAPY
451
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM
263
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES
349
METABOLIC BRAIN DISEASE
563
SCI Abstract
search
ALL
RECOMMENDED
+
Effects of a six‐month low‐carbohydrate diet on glycemic control, body composition and cardiovascular risk factors in patients with type 2 diabetes: an open‐label RCT
Abstract Aims To investigate the efficacy and safety of a non-calorie-restricted low-carbohydrate diet (LCD) on glycemic c...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Dulaglutide and Incident Atrial Fibrillation or Flutter in patients with type 2 Diabetes; a post‐hoc analysis from the REWIND Randomized Trial
Abstract Aims Diabetes mellitus is an independent risk factor for atrial fibrillation or atrial flutter (atrial arrythmia,...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Reduction of clinically important low glucose excursions with a long‐term implantable continuous glucose monitoring (CGM) system in adults with type 1 diabetes prone to hypoglycemia. France Adoption randomized clinical trial
Abstract Aim This trial assessed the outcomes on glucose control of the implantable Eversense real-time continuous glucose...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Acute effects of linagliptin on intact and total GLP‐1 and GIP levels in insulin‐dependent type 2 diabetic patients with and without moderate renal impairment
Abstract Aims Impaired renal function is a frequent complication in patients with type 2 diabetes mellitus (T2DM). The goa...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Understanding the clinical implications of differences between GMI and HbA1c
Abstract Laboratory measured glycosylated hemoglobin (HbA1c) is the gold standard for assessing glycemic control in people...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Quételet (Body Mass) Index and Effects of Dapagliflozin in CKD
Abstract Aims This post-hoc analysis of DAPA-CKD (NCT03036150) assessed the effects of dapagliflozin in patients with chro...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Efficacy and safety of high‐dose GLP‐1, GLP‐1/GIP and GLP‐1/glucagon receptor agonists in type 2 diabetes
Abstract Background GLP-1 receptor agonists (GLP-1 RAs) have become agents of choice for people with type 2 diabetes (T2D)...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Efficacy and safety of imeglimin add‐on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3): A randomized, double‐blind, placebo‐controlled phase 3 trial with a 36‐week open‐label extension period
Abstract Aims To evaluate the efficacy and safety of imeglimin for up to 52 weeks as combination therapy with insul...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Combined SGLT‐2 and ACE inhibition upregulates the renin‐angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double‐blind, placebo‐controlled exploratory trial
ABSTRACT Aims Sodium glucose co-transporter-2 inhibitors (SGLT-2i) improve cardiorenal outcomes in chronic kidney disease ...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: a post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials
ABSTRACT Aims Bempedoic acid inhibits ATP-citrate lyase (ACL), an enzyme in the cholesterol synthesis pathway. Mendelian r...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin‐R with the US‐licensed Humulin® R formulation in healthy subjects: Results from the RHINE‐1 (Recombinant Human INsulin Equivalence‐1) study
Abstract Aims The aim of RHINE-1, a double-blind, randomized, two-treatment, two-period, two-sequence crossover study, was...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Elevated liver enzymes and comorbidities in type 2 diabetes: A multicentre analysis of 51 645 patients from the Diabetes Prospective Follow‐up (DPV) database
Abstract Aim To assess the prevalence of elevated liver enzymes and associated diabetes-related comorbidities in type 2 di...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Improving beta‐cell secretory function and glycaemia in young‐onset type 2 diabetes: A pilot, 12‐month, randomized trial of a novel, continuous glucose monitor‐guided, rapid treatment intensification strategy incorporating empagliflozin and liraglutide
1 BACKGROUND Young-onset type 2 diabetes (YT2D) is characterized by poorer glycaemic control, a higher ...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Long‐term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52‐week, open‐label, multicentre phase 3 trial
Abstract Aim To evaluate the safety and efficacy of imeglimin for 52 weeks as monotherapy or combination therapy wi...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Efficacy and safety of evogliptin in patients with type 2 diabetes and non‐alcoholic fatty liver disease: A multicentre, double‐blind, randomized, comparative trial
1 INTRODUCTION The prevalence of non-alcoholic fatty liver disease (NAFLD) is approximately 25% in both...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Effect of upper gastrointestinal disease on the pharmacokinetics of oral semaglutide in subjects with type 2 diabetes
Abstract Aims The glucagon-like peptide-1 analogue, semaglutide, has been co-formulated with the absorption enhancer, sodi...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Pushing the limits of insulin delivery 100 years later: A Case Study of a Race Across Canada
This article has been accepted for publication and undergone full peer review but has not been through the co...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Real‐world data of 12‐month adjunct sodium‐glucose co‐transporter‐2 inhibitor treatment in type 1 diabetes from the German/Austrian DPV registry: Improved HbA1c without diabetic ketoacidosis
1 INTRODUCTION Sodium-glucose co-transporter-2 inhibitors (SGLT2is) represent a class of oral antidiabe...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Where can you wear your libre? Using the FreeStyle Libre Continuous Glucose Monitor on Alternative Sites
Abstract Aims Subcutaneous continuous glucose monitoring (CGMS) has transformed management of Type 1 diabetes (T1DM). The ...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
SGLT‐2 inhibitor for type 1 diabetes ‐ not any more?
This article has been accepted for publication and undergone full peer review but has not been through the co...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
The relationship between hypoglycaemia and glucose variability in type 1 diabetes
1 INTRODUCTION Hypoglycaemia is a considerable barrier to intensified blood glucose management in type ...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Disparity in the rural‐urban distribution of clinical trial sites used in studies cited by diabetes treatment guidelines
1 INTRODUCTION The prevalence of diabetes and the associated complications are higher in rural areas in...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials
Abstract Aim To investigate the association between treatment with dulaglutide and glycaemic variability (GV) in adult pat...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysis
Abstract Aims To conduct a pooled analysis to assess the performance of intermittently scanned continuous glucose monitori...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Metabolically healthy obesity and cardiovascular events: A risk of obesity
Corresponding Author Tomoyuki Kawada MD & PhD Departme...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes and Non‐Alcoholic Fatty Liver Disease: A Multicenter, Double‐blind, Randomized, Comparative trial
Corresponding Author Byung-Wan Lee MD, PhD Division of End...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Cost‐Effectiveness of Second‐Line Empagliflozin versus Liraglutide for Type 2 Diabetes in the United States
Abstract Aims To estimate the cost-effectiveness of sequential use of the sodium-glucose co-transporter 2 inhibitor empagl...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Initial combination of metformin, sitagliptin, and empagliflozin in drug‐naïve patients with type 2 diabetes: Safety and metabolic effects
Corresponding Author Soo Lim MD Department of Internal Med...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non‐Asian populations of the EMPA‐REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease
Abstract Aims The sodium-glucose co-transporter-2 inhibitor empagliflozin reduced the total burden of cardiovascular morta...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: A population‐based analysis between 2010‐2020
Abstract Aim To examine trends in basal insulin prescribing in older adults with CKD. Materials and methods We conducted a...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Load More
Modal title
×
Modal title
×
Share
Login
Global News and Health Forum
Join Now!
Member Login
Remember me
Forgot password?
Or using
Linkedin